| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |